Bayridge Sunset Pk Dialysis Ctr is a medicare approved dialysis facility center in Brooklyn, New York and it has 26 dialysis stations. It is located in Kings county at 140 58th Street, Brooklyn, NY, 11220. You can reach out to the office of Bayridge Sunset Pk Dialysis Ctr at (718) 567-0255. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. Bayridge Sunset Pk Dialysis Ctr has the following ownership type - Profit. It was first certified by medicare in November, 1995. The medicare id for this facility is 332560 and it accepts patients under medicare ESRD program.
| Name | Bayridge Sunset Pk Dialysis Ctr |
|---|---|
| Location | 140 58th Street, Brooklyn, New York |
| No. of Dialysis Stations | 26 |
| Medicare ID | 332560 |
| Managed By | Independent |
| Ownership Type | Profit |
| Late Shifts | Yes |
| 140 58th Street, Brooklyn, New York, 11220 | |
| (718) 567-0255 | |
News Archive
New York Blood Center today announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease.
AWHR was proud to participate in the Relay For Life of Palm Bay event on April 6, 2013. Eight AWHR employees participated in the event along with 44 other teams and more than 600 participants!
A new study published on the preprint server medRxiv* by researchers from Iceland and the U.S. shows how treatment with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) does not raise angiotensin-converting enzyme 2 (ACE2) levels in human serum – and cautions against the discontinuation of these drugs among patients affected with coronavirus disease (COVID-19).
In this post in PSI's "Healthy Lives" blog, "PSI's Nutrition Research Adviser Dr. Abel Irena talks with Saul Morris, senior program officer at the Bill & Melinda Gates Foundation, about progress that has been made in child health."
› Verified 7 days ago
| NPI Number | 1336175678 |
| Doing Business As | Bayridge Sunset Park Dialysis Center Inc |
| Address | 140 58th St Brooklyn, New York, 11220 |
| Phone Number | (718) 567-0255 |
News Archive
New York Blood Center today announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease.
AWHR was proud to participate in the Relay For Life of Palm Bay event on April 6, 2013. Eight AWHR employees participated in the event along with 44 other teams and more than 600 participants!
A new study published on the preprint server medRxiv* by researchers from Iceland and the U.S. shows how treatment with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) does not raise angiotensin-converting enzyme 2 (ACE2) levels in human serum – and cautions against the discontinuation of these drugs among patients affected with coronavirus disease (COVID-19).
In this post in PSI's "Healthy Lives" blog, "PSI's Nutrition Research Adviser Dr. Abel Irena talks with Saul Morris, senior program officer at the Bill & Melinda Gates Foundation, about progress that has been made in child health."
› Verified 7 days ago
| NPI Number | 1528272275 |
| Doing Business As | Bay Ridge Sunset Park Dialysis Center |
| Address | 140 58th St Bldg B Brooklyn, New York, 11220 |
| Phone Number | (718) 567-0255 |
News Archive
New York Blood Center today announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease.
AWHR was proud to participate in the Relay For Life of Palm Bay event on April 6, 2013. Eight AWHR employees participated in the event along with 44 other teams and more than 600 participants!
A new study published on the preprint server medRxiv* by researchers from Iceland and the U.S. shows how treatment with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) does not raise angiotensin-converting enzyme 2 (ACE2) levels in human serum – and cautions against the discontinuation of these drugs among patients affected with coronavirus disease (COVID-19).
In this post in PSI's "Healthy Lives" blog, "PSI's Nutrition Research Adviser Dr. Abel Irena talks with Saul Morris, senior program officer at the Bill & Melinda Gates Foundation, about progress that has been made in child health."
› Verified 7 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 62% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 20% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 18% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 60% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 31% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 9% | 14% |
News Archive
New York Blood Center today announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease.
AWHR was proud to participate in the Relay For Life of Palm Bay event on April 6, 2013. Eight AWHR employees participated in the event along with 44 other teams and more than 600 participants!
A new study published on the preprint server medRxiv* by researchers from Iceland and the U.S. shows how treatment with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) does not raise angiotensin-converting enzyme 2 (ACE2) levels in human serum – and cautions against the discontinuation of these drugs among patients affected with coronavirus disease (COVID-19).
In this post in PSI's "Healthy Lives" blog, "PSI's Nutrition Research Adviser Dr. Abel Irena talks with Saul Morris, senior program officer at the Bill & Melinda Gates Foundation, about progress that has been made in child health."
› Verified 7 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 53% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 25% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 22% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 45% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 41% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 14% | 12% |
News Archive
New York Blood Center today announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease.
AWHR was proud to participate in the Relay For Life of Palm Bay event on April 6, 2013. Eight AWHR employees participated in the event along with 44 other teams and more than 600 participants!
A new study published on the preprint server medRxiv* by researchers from Iceland and the U.S. shows how treatment with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) does not raise angiotensin-converting enzyme 2 (ACE2) levels in human serum – and cautions against the discontinuation of these drugs among patients affected with coronavirus disease (COVID-19).
In this post in PSI's "Healthy Lives" blog, "PSI's Nutrition Research Adviser Dr. Abel Irena talks with Saul Morris, senior program officer at the Bill & Melinda Gates Foundation, about progress that has been made in child health."
› Verified 7 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 74% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 26% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 59% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 25% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 16% | 12% |
News Archive
New York Blood Center today announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease.
AWHR was proud to participate in the Relay For Life of Palm Bay event on April 6, 2013. Eight AWHR employees participated in the event along with 44 other teams and more than 600 participants!
A new study published on the preprint server medRxiv* by researchers from Iceland and the U.S. shows how treatment with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) does not raise angiotensin-converting enzyme 2 (ACE2) levels in human serum – and cautions against the discontinuation of these drugs among patients affected with coronavirus disease (COVID-19).
In this post in PSI's "Healthy Lives" blog, "PSI's Nutrition Research Adviser Dr. Abel Irena talks with Saul Morris, senior program officer at the Bill & Melinda Gates Foundation, about progress that has been made in child health."
› Verified 7 days ago
| Dialysis patients with Hemoglobin data | 75 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 16 |
News Archive
New York Blood Center today announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease.
AWHR was proud to participate in the Relay For Life of Palm Bay event on April 6, 2013. Eight AWHR employees participated in the event along with 44 other teams and more than 600 participants!
A new study published on the preprint server medRxiv* by researchers from Iceland and the U.S. shows how treatment with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) does not raise angiotensin-converting enzyme 2 (ACE2) levels in human serum – and cautions against the discontinuation of these drugs among patients affected with coronavirus disease (COVID-19).
In this post in PSI's "Healthy Lives" blog, "PSI's Nutrition Research Adviser Dr. Abel Irena talks with Saul Morris, senior program officer at the Bill & Melinda Gates Foundation, about progress that has been made in child health."
› Verified 7 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 175 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 1681 |
| Percentage of adult patients getting regular hemodialysis at the center | 94 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
New York Blood Center today announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease.
AWHR was proud to participate in the Relay For Life of Palm Bay event on April 6, 2013. Eight AWHR employees participated in the event along with 44 other teams and more than 600 participants!
A new study published on the preprint server medRxiv* by researchers from Iceland and the U.S. shows how treatment with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) does not raise angiotensin-converting enzyme 2 (ACE2) levels in human serum – and cautions against the discontinuation of these drugs among patients affected with coronavirus disease (COVID-19).
In this post in PSI's "Healthy Lives" blog, "PSI's Nutrition Research Adviser Dr. Abel Irena talks with Saul Morris, senior program officer at the Bill & Melinda Gates Foundation, about progress that has been made in child health."
› Verified 7 days ago
| Adult patients getting regular peritoneal dialysis at the center | 3 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 27 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
New York Blood Center today announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease.
AWHR was proud to participate in the Relay For Life of Palm Bay event on April 6, 2013. Eight AWHR employees participated in the event along with 44 other teams and more than 600 participants!
A new study published on the preprint server medRxiv* by researchers from Iceland and the U.S. shows how treatment with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) does not raise angiotensin-converting enzyme 2 (ACE2) levels in human serum – and cautions against the discontinuation of these drugs among patients affected with coronavirus disease (COVID-19).
In this post in PSI's "Healthy Lives" blog, "PSI's Nutrition Research Adviser Dr. Abel Irena talks with Saul Morris, senior program officer at the Bill & Melinda Gates Foundation, about progress that has been made in child health."
› Verified 7 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Bayridge Sunset Pk Dialysis Ctr with elevated calcium levels.
| Patients with hypercalcemia | 194 |
| Hypercalcemia patient months | 1870 |
| Patients with Serumphosphor | 193 |
| Patients with Serumphosphor less than 3.5 mg/dL | 6 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 26 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 25 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 27 |
| Patients with Serumphosphor greater than 7 mg/dL | 16 |
News Archive
New York Blood Center today announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease.
AWHR was proud to participate in the Relay For Life of Palm Bay event on April 6, 2013. Eight AWHR employees participated in the event along with 44 other teams and more than 600 participants!
A new study published on the preprint server medRxiv* by researchers from Iceland and the U.S. shows how treatment with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) does not raise angiotensin-converting enzyme 2 (ACE2) levels in human serum – and cautions against the discontinuation of these drugs among patients affected with coronavirus disease (COVID-19).
In this post in PSI's "Healthy Lives" blog, "PSI's Nutrition Research Adviser Dr. Abel Irena talks with Saul Morris, senior program officer at the Bill & Melinda Gates Foundation, about progress that has been made in child health."
› Verified 7 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 99 |
| Patient months included in arterial venous fistula and catheter summaries | 903 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 71 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 16 |
News Archive
New York Blood Center today announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease.
AWHR was proud to participate in the Relay For Life of Palm Bay event on April 6, 2013. Eight AWHR employees participated in the event along with 44 other teams and more than 600 participants!
A new study published on the preprint server medRxiv* by researchers from Iceland and the U.S. shows how treatment with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) does not raise angiotensin-converting enzyme 2 (ACE2) levels in human serum – and cautions against the discontinuation of these drugs among patients affected with coronavirus disease (COVID-19).
In this post in PSI's "Healthy Lives" blog, "PSI's Nutrition Research Adviser Dr. Abel Irena talks with Saul Morris, senior program officer at the Bill & Melinda Gates Foundation, about progress that has been made in child health."
› Verified 7 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 123 |
| Hospitalization Rate in facility | 167.1 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 269 |
| Hospitalization Rate: Lower Confidence Limit | 111.5 |
News Archive
New York Blood Center today announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease.
AWHR was proud to participate in the Relay For Life of Palm Bay event on April 6, 2013. Eight AWHR employees participated in the event along with 44 other teams and more than 600 participants!
A new study published on the preprint server medRxiv* by researchers from Iceland and the U.S. shows how treatment with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) does not raise angiotensin-converting enzyme 2 (ACE2) levels in human serum – and cautions against the discontinuation of these drugs among patients affected with coronavirus disease (COVID-19).
In this post in PSI's "Healthy Lives" blog, "PSI's Nutrition Research Adviser Dr. Abel Irena talks with Saul Morris, senior program officer at the Bill & Melinda Gates Foundation, about progress that has been made in child health."
› Verified 7 days ago
The rate of readmission show you whether patients who were being treated regularly at Bayridge Sunset Pk Dialysis Ctr were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 23.2 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 30.2 |
| Readmission Rate: Lower Confidence Limit | 17.2 |
News Archive
New York Blood Center today announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease.
AWHR was proud to participate in the Relay For Life of Palm Bay event on April 6, 2013. Eight AWHR employees participated in the event along with 44 other teams and more than 600 participants!
A new study published on the preprint server medRxiv* by researchers from Iceland and the U.S. shows how treatment with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) does not raise angiotensin-converting enzyme 2 (ACE2) levels in human serum – and cautions against the discontinuation of these drugs among patients affected with coronavirus disease (COVID-19).
In this post in PSI's "Healthy Lives" blog, "PSI's Nutrition Research Adviser Dr. Abel Irena talks with Saul Morris, senior program officer at the Bill & Melinda Gates Foundation, about progress that has been made in child health."
› Verified 7 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Bayridge Sunset Pk Dialysis Ctr get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .93 (As Expected) |
| SIR: Upper Confidence Limit | 1.57 |
| SIR: Lower Confidence Limit | .5 |
News Archive
New York Blood Center today announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease.
AWHR was proud to participate in the Relay For Life of Palm Bay event on April 6, 2013. Eight AWHR employees participated in the event along with 44 other teams and more than 600 participants!
A new study published on the preprint server medRxiv* by researchers from Iceland and the U.S. shows how treatment with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) does not raise angiotensin-converting enzyme 2 (ACE2) levels in human serum – and cautions against the discontinuation of these drugs among patients affected with coronavirus disease (COVID-19).
In this post in PSI's "Healthy Lives" blog, "PSI's Nutrition Research Adviser Dr. Abel Irena talks with Saul Morris, senior program officer at the Bill & Melinda Gates Foundation, about progress that has been made in child health."
› Verified 7 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Bayridge Sunset Pk Dialysis Ctr's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 108 |
| Transfusion Rate in facility | 41.6 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 81.1 |
| Transfusion Rate: Lower Confidence Limit | 23.2 |
News Archive
New York Blood Center today announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease.
AWHR was proud to participate in the Relay For Life of Palm Bay event on April 6, 2013. Eight AWHR employees participated in the event along with 44 other teams and more than 600 participants!
A new study published on the preprint server medRxiv* by researchers from Iceland and the U.S. shows how treatment with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) does not raise angiotensin-converting enzyme 2 (ACE2) levels in human serum – and cautions against the discontinuation of these drugs among patients affected with coronavirus disease (COVID-19).
In this post in PSI's "Healthy Lives" blog, "PSI's Nutrition Research Adviser Dr. Abel Irena talks with Saul Morris, senior program officer at the Bill & Melinda Gates Foundation, about progress that has been made in child health."
› Verified 7 days ago
The rate of mortality show you whether patients who were being treated regularly at Bayridge Sunset Pk Dialysis Ctr lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 759 |
| Mortality Rate in facility | 13.1 (Better than Expected) |
| Mortality Rate: Upper Confidence Limit | 16.3 |
| Mortality Rate: Lower Confidence Limit | 10.4 |
News Archive
New York Blood Center today announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease.
AWHR was proud to participate in the Relay For Life of Palm Bay event on April 6, 2013. Eight AWHR employees participated in the event along with 44 other teams and more than 600 participants!
A new study published on the preprint server medRxiv* by researchers from Iceland and the U.S. shows how treatment with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) does not raise angiotensin-converting enzyme 2 (ACE2) levels in human serum – and cautions against the discontinuation of these drugs among patients affected with coronavirus disease (COVID-19).
In this post in PSI's "Healthy Lives" blog, "PSI's Nutrition Research Adviser Dr. Abel Irena talks with Saul Morris, senior program officer at the Bill & Melinda Gates Foundation, about progress that has been made in child health."
› Verified 7 days ago
Kingsbrook Jewish Medical Center Location: 585 Schenectady Ave, Brooklyn, New York, 11203 Phone: (718) 604-5591 |
NYC Health + Hospitals/Kings County Location: 451 Clarkson Avenue, Brooklyn, New York, 11203 Phone: (718) 613-8151 |
Brookdale Hospital & Medical Center Location: 1 Brookdale Plaza, Brooklyn, New York, 11212 Phone: (718) 240-5727 |
News Archive
New York Blood Center today announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease.
AWHR was proud to participate in the Relay For Life of Palm Bay event on April 6, 2013. Eight AWHR employees participated in the event along with 44 other teams and more than 600 participants!
A new study published on the preprint server medRxiv* by researchers from Iceland and the U.S. shows how treatment with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) does not raise angiotensin-converting enzyme 2 (ACE2) levels in human serum – and cautions against the discontinuation of these drugs among patients affected with coronavirus disease (COVID-19).
In this post in PSI's "Healthy Lives" blog, "PSI's Nutrition Research Adviser Dr. Abel Irena talks with Saul Morris, senior program officer at the Bill & Melinda Gates Foundation, about progress that has been made in child health."
› Verified 7 days ago